Three-Year Follow-Up of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Long-Term Phase 3 EMBARK Trial Results
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, and copyright information, please see the full text online (see “read the peer-reviewed publication” opposite).
Authors
- Alexander Peter Murphy (ORCID: https://orcid.org/0000-0003-4244-0541)
- Louise R. Rodino‐Klapac (ORCID: https://orcid.org/0000-0002-8966-5177)
- Craig Mitchell Zaidman (ORCID: https://orcid.org/0000-0002-1255-5877)
- M. Vivien (ORCID: https://orcid.org/0009-0009-6552-9152)
- Eugenio Maria Mercuri (ORCID: https://orcid.org/0000-0002-9851-5365)
- Emma Ciafaloni (ORCID: https://orcid.org/0000-0002-3925-3289)
- Matthew Furgerson
- Aravindhan Veerapandiyan (ORCID: https://orcid.org/0000-0002-3065-3956)
- Crystal M. Proud (ORCID: https://orcid.org/0009-0008-8416-9335)
- Francesco Muntoni
- Damon R. Asher (ORCID: https://orcid.org/0009-0009-3907-9709)
- Hirofumi Komaki (ORCID: https://orcid.org/0000-0002-0659-1417)
- Craig M. McDonald (ORCID: https://orcid.org/0000-0002-8779-3220)
- Pooneh Pordeli (ORCID: https://orcid.org/0000-0002-4318-583X)
- Carmen Leon‐Astudillo (ORCID: https://orcid.org/0000-0003-1800-4301)
- Carmen Olga Torre (ORCID: https://orcid.org/0000-0002-2417-7164)
- Nascimento Andres
- Marianna Manfrini
- Jerry R. Mendell (ORCID: https://orcid.org/0009-0006-3966-6303)
- Marianne Gerber (ORCID: https://orcid.org/0000-0002-3823-6049)
- Ulrike Schara (ORCID: https://orcid.org/0000-0001-5833-2751)
- Nicolas Deconinck
- on behalf of the EMBARK Study Group
- Adis journals on behalf of
- Yi Sun
Publication Details
- Journal
- Figshare
- Published
- 2026-10-28
- DOI
- https://doi.org/10.6084/m9.figshare.33994398
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00